Filing Details
- Accession Number:
- 0001493152-17-002852
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-27 06:15:26
- Reporting Period:
- 2015-12-29
- Filing Date:
- 2017-03-27
- Accepted Time:
- 2017-03-27 06:15:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1354591 | Petlife Pharmaceuticals Inc. | PTLF | Industrial Organic Chemicals (2860) | 331133537 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1677900 | T Ralph Salvagno | 38 West Main Street Hancock MD 21750 | Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-29 | 100,000 | $0.25 | 100,000 | No | 4 | P | Indirect | By Grand Street Ventures, LLC |
| Common Stock | Acquisiton | 2016-02-12 | 250,000 | $0.64 | 350,000 | No | 4 | P | Indirect | By Grand Street Ventures, LLC |
| Common Stock | Acquisiton | 2016-02-12 | 540,000 | $0.46 | 890,000 | No | 4 | P | Indirect | By Grand Street Ventures, LLC |
| Common Stock | Acquisiton | 2016-02-12 | 250,000 | $0.64 | 1,140,000 | No | 4 | P | Indirect | By Grand Street Ventures, LLC |
| Common Stock | Acquisiton | 2017-02-23 | 11,160,000 | $0.50 | 12,300,000 | No | 4 | A | Indirect | By Grand Street Ventures, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Grand Street Ventures, LLC |
| No | 4 | P | Indirect | By Grand Street Ventures, LLC |
| No | 4 | P | Indirect | By Grand Street Ventures, LLC |
| No | 4 | P | Indirect | By Grand Street Ventures, LLC |
| No | 4 | A | Indirect | By Grand Street Ventures, LLC |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2016-06-09 | 2,000,000 | $0.00 | 2,000,000 | $0.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,000,000 | 2016-06-09 | 2019-06-09 | No | 4 | A | Direct |
Footnotes
- Adjusted for the issuer's 1-for-5 reverse stock split effected in September 2016.
- For services valued at $0.50/share.
- The issuer granted Dr. Salvagno options to purchase 2,000,000 shares of common stock at an exercise price of 50% of the market price or $0.25/share, whichever is higher.
Billionaire Hedge Funds
